Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Hager

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
BMC Geriatrics|February 22, 2024
Study protocol of the OrkA project: orofacial and communicative activation in old age- a cluster randomized prevention study in long-term care facilities in Lower Saxony, GermanyWenke Walther, Martin Ptok, Klaus Hager, et al.
International Journal of Language & Communication Disorders|March 20, 2026
Qualitative Insights on Preventive Group Training in LTC Facilities: Key Influencing FactorsIsabell Fesser, Klaus Hager, Simone Miller, et al.
Dementia and Geriatric Cognitive Disorders|March 11, 2003
An observational clinical study of the efficacy and tolerability of donepezil in the treatment of Alzheimer's diseaseKlaus Hager, Pasquale Calabrese, Lutz Frölich, et al.
BMC Geriatrics|October 17, 2015
Living with and dying from advanced heart failure: understanding the needs of older patients at the end of lifeKatharina Klindtworth, Peter Oster, Klaus Hager, et al.
European Journal of Ageing|August 15, 2017
'Who is going to explain it to me so that I understand?' Health care needs and experiences of older patients with advanced heart failureMiriam G Gerlich, Katharina Klindtworth, Peter Oster, et al.
Journal of Neurochemistry|January 25, 2005
Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairmentNaila Ahmed, Usman Ahmed, Paul J Thornalley, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|August 24, 2019
Post-discharge adjustment of medication in geriatric patients : A prospective cohort studyOlaf Krause, Stefanie Glaubitz, Klaus Hager, et al.
Pharmacology & Therapeutics|September 23, 2006
Lipoic acid as a novel treatment for Alzheimer's disease and related dementiasLina Holmquist, Grant Stuchbury, Katrin Berbaum, et al.
International Journal of Geriatric Psychiatry|January 13, 2004
A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's diseaseRoy W Jones, Hilkka Soininen, Klaus Hager, et al.
Current Medical Research and Opinion|November 9, 2007
Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapyParaskevi Sakka, Magda Tsolaki, Jakub Hort, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
BMC Geriatrics|February 22, 2024
Study protocol of the OrkA project: orofacial and communicative activation in old age- a cluster randomized prevention study in long-term care facilities in Lower Saxony, GermanyWenke Walther, Martin Ptok, Klaus Hager, et al.
International Journal of Language & Communication Disorders|March 20, 2026
Qualitative Insights on Preventive Group Training in LTC Facilities: Key Influencing FactorsIsabell Fesser, Klaus Hager, Simone Miller, et al.
Dementia and Geriatric Cognitive Disorders|March 11, 2003
An observational clinical study of the efficacy and tolerability of donepezil in the treatment of Alzheimer's diseaseKlaus Hager, Pasquale Calabrese, Lutz Frölich, et al.
BMC Geriatrics|October 17, 2015
Living with and dying from advanced heart failure: understanding the needs of older patients at the end of lifeKatharina Klindtworth, Peter Oster, Klaus Hager, et al.
European Journal of Ageing|August 15, 2017
'Who is going to explain it to me so that I understand?' Health care needs and experiences of older patients with advanced heart failureMiriam G Gerlich, Katharina Klindtworth, Peter Oster, et al.
Journal of Neurochemistry|January 25, 2005
Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairmentNaila Ahmed, Usman Ahmed, Paul J Thornalley, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|August 24, 2019
Post-discharge adjustment of medication in geriatric patients : A prospective cohort studyOlaf Krause, Stefanie Glaubitz, Klaus Hager, et al.
Pharmacology & Therapeutics|September 23, 2006
Lipoic acid as a novel treatment for Alzheimer's disease and related dementiasLina Holmquist, Grant Stuchbury, Katrin Berbaum, et al.
International Journal of Geriatric Psychiatry|January 13, 2004
A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's diseaseRoy W Jones, Hilkka Soininen, Klaus Hager, et al.
Current Medical Research and Opinion|November 9, 2007
Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapyParaskevi Sakka, Magda Tsolaki, Jakub Hort, et al.
Pageof 3